,

Lucía Ageitos1, Andreia Boaro1, Angela Cesaro1

  • 1Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA; Penn Institute for Computational Science, University of Pennsylvania, Philadelphia, PA, USA.

PubMed
概括

灵感来自青抗微生物 (AMP) 的新合成,有效地向有害的阴性细菌,而不损害有益的微生物或引起耐药性. 这些有希望的临床前候选药物为打击抗生素耐药性的新方法提供了机会.